BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18709395)

  • 1. Application of oxygen uptake rate and response surface methodology for erythromycin production by Saccharopolyspora erythraea.
    Zou X; Hang HF; Chen CF; Chu J; Zhuang YP; Zhang SL
    J Ind Microbiol Biotechnol; 2008 Dec; 35(12):1637-42. PubMed ID: 18709395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical parameters of Saccharopolyspora erythraea during feeding ammonium sulphate in erythromycin biosynthesis phase.
    Zou X; Li WJ; Zeng W; Hang HF; Chu J; Zhuang YP; Zhang SL
    Prikl Biokhim Mikrobiol; 2013; 49(2):190-6. PubMed ID: 23795479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea.
    Minas W; Brünker P; Kallio PT; Bailey JE
    Biotechnol Prog; 1998; 14(4):561-6. PubMed ID: 9694676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glucose RQ-feedback control leading to improved erythromycin production by a recombinant strain Saccharopolyspora erythraea ZL1004 and its scale-up to 372-m(3) fermenter.
    Chen Y; Wang Z; Chu J; Xi B; Zhuang Y
    Bioprocess Biosyst Eng; 2015 Jan; 38(1):105-12. PubMed ID: 25042891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of erythromycin production by Saccharopolyspora erythraea in molasses based medium through cultivation medium optimization.
    El-Enshasy HA; Mohamed NA; Farid MA; El-Diwany AI
    Bioresour Technol; 2008 Jul; 99(10):4263-8. PubMed ID: 17936622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen uptake rate optimization with nitrogen regulation for erythromycin production and scale-up from 50 L to 372 m3 scale.
    Zou X; Hang HF; Chu J; Zhuang YP; Zhang SL
    Bioresour Technol; 2009 Feb; 100(3):1406-12. PubMed ID: 18929481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rational design of a 500 m
    Tan X; Li C; Guo M
    Sheng Wu Gong Cheng Xue Bao; 2022 Dec; 38(12):4692-4704. PubMed ID: 36593203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharopolyspora erythraea-catalyzed bioconversion of 6-deoxyerythronolide B analogs for production of novel erythromycins.
    Carreras C; Frykman S; Ou S; Cadapan L; Zavala S; Woo E; Leaf T; Carney J; Burlingame M; Patel S; Ashley G; Licari P
    J Biotechnol; 2002 Jan; 92(3):217-28. PubMed ID: 11689246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design-Build-Test-Learn approach.
    Shao M; Xu F; Ke X; Huang M; Chu J
    Biotechnol J; 2024 May; 19(5):e2400039. PubMed ID: 38797723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and engineering of the Lrp/AsnC family regulator SACE_5717 for erythromycin overproduction in Saccharopolyspora erythraea.
    Liu J; Chen Y; Li L; Yang E; Wang Y; Wu H; Zhang L; Wang W; Zhang B
    J Ind Microbiol Biotechnol; 2019 Jul; 46(7):1013-1024. PubMed ID: 31016583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of Saccharopolyspora erythraea strains after protoplast regeneration.
    Rajnisz A; Solecka J; Kurzatkowski W
    Folia Microbiol (Praha); 2005; 50(1):13-8. PubMed ID: 15954528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the interaction of fermentation and microfiltration operations: erythromycin recovery from Saccharopolyspora erythraea fermentation broths.
    Davies JL; Baganz F; Ison AP; Lye GJ
    Biotechnol Bioeng; 2000 Aug; 69(4):429-39. PubMed ID: 10862681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the flow of propionate into TCA cycle through a mutB knockout leads to a significant increase of erythromycin production by an industrial strain of Saccharopolyspora erythraea.
    Chen C; Hong M; Chu J; Huang M; Ouyang L; Tian X; Zhuang Y
    Bioprocess Biosyst Eng; 2017 Feb; 40(2):201-209. PubMed ID: 27709326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of erythromycin A production with feeding available nitrogen sources in erythromycin biosynthesis phase.
    Zou X; Hang HF; Chu J; Zhuang YP; Zhang SL
    Bioresour Technol; 2009 Jul; 100(13):3358-65. PubMed ID: 19268575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput optimization of the chemically defined synthetic medium for the production of erythromycin A.
    Hong M; Liao J; Chu J
    Bioprocess Biosyst Eng; 2018 Oct; 41(10):1529-1538. PubMed ID: 30003380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking out of tailoring genes eryK and eryG in an industrial erythromycin-producing strain of Saccharopolyspora erythraea leading to overproduction of erythromycin B, C and D at different conversion ratios.
    Zhang Q; Wu J; Qian J; Chu J; Zhuang Y; Zhang S; Liu W
    Lett Appl Microbiol; 2011 Feb; 52(2):129-37. PubMed ID: 21175699
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hong M; Mou H; Liu X; Huang M; Chu J
    Bioprocess Biosyst Eng; 2017 Sep; 40(9):1337-1348. PubMed ID: 28567527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting and engineering of the TetR family regulator SACE_7301 for enhanced erythromycin production in Saccharopolyspora erythraea.
    Wu H; Chen M; Mao Y; Li W; Liu J; Huang X; Zhou Y; Ye BC; Zhang L; Weaver DT; Zhang B
    Microb Cell Fact; 2014 Nov; 13():158. PubMed ID: 25391994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SACE_5599, a putative regulatory protein, is involved in morphological differentiation and erythromycin production in Saccharopolyspora erythraea.
    Kirm B; Magdevska V; Tome M; Horvat M; Karničar K; Petek M; Vidmar R; Baebler S; Jamnik P; Fujs Š; Horvat J; Fonovič M; Turk B; Gruden K; Petković H; Kosec G
    Microb Cell Fact; 2013 Dec; 12():126. PubMed ID: 24341557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the methods of sterilization on the quality of nutrient media and on the level of antibiotic production].
    Motina GL; Kalinina NM; Tarasova TM; Bryzgalova TE; Nekliudov AD; Mal'tsev NI; Lur'e LM
    Antibiot Khimioter; 1991 Dec; 36(12):3-6. PubMed ID: 1814272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.